TickerFacts.

Universe Pharmaceuticals Inc (UPC): Shareholders' Equity

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-09-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$56.13B
As of 2025-09-30. As filed; likely tagged in the wrong unit
2019-09-30: $12.38M2020-09-30: $20.80M2021-09-30: $58.93M2022-09-30: $35.33M2023-09-30: $27.97B2024-09-30: $45.50B2025-09-30: $56.13B$56.13B
2019-09-30 Shareholders' Equity (USD) 2025-09-30
Period endedShareholders' EquityChange YoYSource filing
2025-09-30$56.13Bn/a2026-01-29, Balance as of period end
2024-09-30$45.50Bn/a2026-01-29, Balance as of period end
2023-09-30$27.97Bn/a2026-01-29, Balance as of period end
2022-09-30$35.33Mn/a2025-04-29, Balance as of period end
2021-09-30$58.93Mn/a2024-01-30, Balance as of period end
2020-09-30$20.80Mn/a2023-02-10, Balance as of period end
2019-09-30$12.38Mn/a2022-01-31, Balance as of period end